Japanese spotted fever
| Japanese spotted fever | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Fever, rash, headache, muscle pain |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | Rickettsia japonica |
| Risks | |
| Diagnosis | Serology, PCR |
| Differential diagnosis | |
| Prevention | Avoidance of tick bites |
| Treatment | Doxycycline |
| Medication | |
| Prognosis | Generally good with treatment |
| Frequency | |
| Deaths | |
Japanese Spotted Fever (JSF) is a bacterial infection caused by Rickettsia japonica, a species of bacteria in the genus Rickettsia. The disease is transmitted to humans through the bite of an infected tick. It is primarily found in Japan, but cases have also been reported in South Korea and China.
Symptoms[edit]
The symptoms of Japanese Spotted Fever typically appear within a week of a tick bite and include fever, headache, muscle pain, and a characteristic rash. The rash usually begins on the extremities and spreads to the trunk. In severe cases, the disease can cause complications such as meningitis, pneumonia, and kidney failure.
Diagnosis[edit]
Diagnosis of Japanese Spotted Fever is based on clinical symptoms and confirmed by laboratory tests. The most common test is the indirect immunofluorescence assay (IFA), which detects antibodies to Rickettsia japonica in the patient's blood.
Treatment[edit]
Treatment for Japanese Spotted Fever typically involves a course of the antibiotic doxycycline. If treated promptly, most patients recover fully. However, if left untreated, the disease can be fatal.
Prevention[edit]
Prevention of Japanese Spotted Fever involves avoiding tick bites through the use of insect repellent, wearing long sleeves and pants when in tick-infested areas, and checking for ticks after being outdoors. There is currently no vaccine available for the disease.
Epidemiology[edit]
Japanese Spotted Fever was first identified in Japan in 1984. Since then, the number of cases has been increasing, particularly in the western part of the country. The disease is most common in the summer months when ticks are most active.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian